Global Basal Cell Carcinoma Treatment Market- Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning / Landscape Review & Global Market Size Forecast to 2029
9.41%
CAGR (2023-2029)
6.58 USD Bn.
Market Size
322
Report Pages
147
Market Tables
Overview
Global Basal Cell Carcinoma Treatment Market size is expected to grow at a CAGR of 9.41% throughout the forecast period, reaching nearly US$ 12.35 Bn. by 2029.
Basal Cell Carcinoma Treatment Market Overview:
Basal cell carcinoma is a kind of non-melanocytic cancer that forms from basal cells existing in the lower epidermis. It never spread to other parts of the body, it is normally triggered by the experience to ultraviolet rays. Immunosuppressant drugs are further likely to increase the possibility of basal cell carcinoma as the immune system is inhibited by these drugs. There are several treatment options existing for the basal cell carcinoma like surgery, drugs, and others such as radiation therapy and it may take some time to get completely cured. The frequency of basal cell carcinoma and availability of treatment drives the basal cell carcinoma treatment market.
To know about the Research Methodology :- Request Free Sample Report
The scope of the report includes a detailed study of global and regional markets for Basal Cell Carcinoma Treatment with the reasons given for variants in the growth of the industry in certain regions.
The key aspects driving the growth of market over the projected period are rise in several types of skin disorders together with melanoma and others. Increased frequency of cutaneous malignancies is further anticipated to drive the growth of market. According to American Cancer Society 2021 report, an estimated xx K men and xx K women in the U.S.A. were detected with melanoma of the skin. Moreover, upsurge in geriatric population, increased prevalence, and favorable reimbursement policies are further anticipated to support the growth of market.
Furthermore, the market is projected to gain significantly from the altering lifestyle of people in emerging economies over the forecast period as it is anticipated to drive demand for better disease treatments, which in turn, is likely to deliver beneficial opportunities for the companies functioning in the global basal cell carcinoma treatment market.
Basal Cell Carcinoma Treatment Market Segment Analysis:
The report on global Basal Cell Carcinoma Treatment market covers segments such as Surgical Treatment Type, Drug Type, Therapy, End User and Region. The Surgical Treatment Type segment includes Surgical Excision, Electrodessication & Cutterage (ED&C), Moh's Surgery and Cryosurgery. Among the Surgical Treatment Type, Surgical Excision is accounted for the largest xx% market share in the global market. The Drug Type segment is further sub-segmented into Topical Treatment, Advanced Medication and Other. Among the Surgical Treatment Type, Advanced Medication is accounted for the largest xx% market share in the global market.
Based on Therapy, the global market is sub-segmented into Radiation Therapy, Photodynamic Therapy (PDT) and Laser Therapy. Amongst them Laser Therapy is accounted for the largest xx% market share in the global market. Based on End User, the global market is sub-segmented into Hospitals, Specialty Clinics and Cancer Research Institutes. Amongst them Specialty Clinics are accounted for the largest xx% market share in the global market.
Regional Insights:
Based on regional segment, the global market is sub-segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, is the currently hold market leadership, which is estimated to persist dominant over the forecast period. The existence of a well-established medical and healthcare infrastructure, growing disbursement on healthcare, and the high frequency of basal cell carcinoma in this region are ready boost the growth of the market for basal cell carcinoma treatment. The Asia Pacific is projected to grow reasonably over the forecast period. Latin America and the Middle East and Africa are anticipated to grow at a significant rate within the forecast period.
Key players operating in the market are Valeant Pharmaceuticals International, Inc., Sun Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Mylan N.V., Bausch Health, Biofrontera, and Merck & Co., Inc. With only a few players are leading the market, however, the competition between these players characterizes the competitive landscape predominant in this market.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global Bnoasal Cell Carcima Treatment market dynamics, structure by identifying and analyzing the market segments and project the global market size.
Further, the report also focuses on the competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the global Basal Cell Carcinoma Treatment market.
Basal Cell Carcinoma Treatment Market Scope: Inquire before buying
| Basal Cell Carcinoma Treatment Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 6.58 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 9.41% | Market Size in 2029: | US $ 12.35 Bn. |
| Segments Covered: | by Surgical Treatment Type | Surgical Excision Electrodessication & Cutterage (ED&C) Moh’s Surgery Cryosurgery |
|
| by Drug Type | Topical Treatment Advanced Medication Other |
||
| by Therapy | Radiation Therapy Photodynamic Therapy (PDT) Laser Therapy |
||
| by End-User | Hospitals Specialty Clinics Cancer Research Institutes |
||
Basal Cell Carcinoma Treatment Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players are:
1. Valeant Pharmaceuticals International, Inc.
2. Sun Pharmaceuticals Ltd.
3. F. Hoffmann-La Roche Ltd.
4. Mylan N.V.
5. Bausch Health,
6. Biofrontera,
7. Merck & Co., Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global Basal Cell Carcinoma Treatment Market?
Ans: North America region holds the highest share in 2022.
2. What is the growth rate of Global Basal Cell Carcinoma Treatment Market?
Ans: The Global market is growing at a CAGR of 9.41% during forecasting period 2023-2029.
3. What is scope of the Global Basal Cell Carcinoma Treatment market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Basal Cell Carcinoma Treatment market?
Ans: The important key players in the Global market are – Valeant Pharmaceuticals International, Inc., Sun Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Mylan N.V., Bausch Health,, Biofrontera,, Merck & Co., and Inc.
5. What is the study period of this market?
Ans: The Global market is studied from 2022 to 2029.
Table of Contents
Global Basal Cell Carcinoma Treatment Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Basal Cell Carcinoma Treatment Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Basal Cell Carcinoma Treatment Market Analysis and Forecast
6.1. Global Basal Cell Carcinoma Treatment Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Basal Cell Carcinoma Treatment Market Analysis and Forecast, By Surgical Treatment Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
7.4. Global Basal Cell Carcinoma Treatment Market Size (US$ Bn) Forecast, By Surgical Treatment Type
7.5. Global Basal Cell Carcinoma Treatment Market Analysis, By Surgical Treatment Type
7.6. Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, By Surgical Treatment Type
8. Global Basal Cell Carcinoma Treatment Market Analysis and Forecast, By Drug Type
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
8.4. Global Basal Cell Carcinoma Treatment Market Size (US$ Bn) Forecast, By Drug Type
8.5. Global Basal Cell Carcinoma Treatment Market Analysis, By Drug Type
8.6. Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, By Drug Type
9. Global Basal Cell Carcinoma Treatment Market Analysis and Forecast, By Therapy
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
9.4. Global Basal Cell Carcinoma Treatment Market Size (US$ Bn) Forecast, By Therapy
9.5. Global Basal Cell Carcinoma Treatment Market Analysis, By Therapy
9.6. Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, By Therapy
10. Global Basal Cell Carcinoma Treatment Market Analysis and Forecast, By End User
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
10.4. Global Basal Cell Carcinoma Treatment Market Size (US$ Bn) Forecast, By End User
10.5. Global Basal Cell Carcinoma Treatment Market Analysis, By End User
10.6. Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, By End User
11. Global Basal Cell Carcinoma Treatment Market Analysis, by Region
11.1. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Region
11.2. Global Basal Cell Carcinoma Treatment Market Size (US$ Bn) Forecast, by Region
11.3. Global Basal Cell Carcinoma Treatment Market Attractiveness Analysis, by Region
12. North America Basal Cell Carcinoma Treatment Market Analysis
12.1. Key Findings
12.2. North America Basal Cell Carcinoma Treatment Market Overview
12.3. North America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
12.4. North America Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
12.4.1. Surgical Excision
12.4.2. Electrodessication & Cutterage (ED&C)
12.4.3. Moh’s Surgery
12.4.4. Cryosurgery
12.5. North America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
12.6. North America Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
12.6.1. Topical Treatment
12.6.2. Advanced Medication
12.6.3. Other
12.7. North America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
12.8. North America Basal Cell Carcinoma Treatment Market Forecast, By Therapy
12.8.1. Radiation Therapy
12.8.2. Photodynamic Therapy (PDT)
12.8.3. Laser Therapy
12.9. North America Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
12.10. North America Basal Cell Carcinoma Treatment Market Forecast, By End User
12.10.1. Hospitals
12.10.2. Specialty Clinics
12.10.3. Cancer Research Institutes
12.11. North America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country
12.12. North America Basal Cell Carcinoma Treatment Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Basal Cell Carcinoma Treatment Market Analysis, by Country
12.14. U.S. Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
12.14.1. Surgical Excision
12.14.2. Electrodessication & Cutterage (ED&C)
12.14.3. Moh’s Surgery
12.14.4. Cryosurgery
12.15. U.S. Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
12.15.1. Topical Treatment
12.15.2. Advanced Medication
12.15.3. Other
12.16. U.S. Basal Cell Carcinoma Treatment Market Forecast, By Therapy
12.16.1. Radiation Therapy
12.16.2. Photodynamic Therapy (PDT)
12.16.3. Laser Therapy
12.17. U.S. Basal Cell Carcinoma Treatment Market Forecast, By End User
12.17.1. Hospitals
12.17.2. Specialty Clinics
12.17.3. Cancer Research Institutes
12.18. Canada Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
12.18.1. Surgical Excision
12.18.2. Electrodessication & Cutterage (ED&C)
12.18.3. Moh’s Surgery
12.18.4. Cryosurgery
12.19. Canada Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
12.19.1. Topical Treatment
12.19.2. Advanced Medication
12.19.3. Other
12.20. Canada Basal Cell Carcinoma Treatment Market Forecast, By Therapy
12.20.1. Radiation Therapy
12.20.2. Photodynamic Therapy (PDT)
12.20.3. Laser Therapy
12.21. Canada Basal Cell Carcinoma Treatment Market Forecast, By End User
12.21.1. Hospitals
12.21.2. Specialty Clinics
12.21.3. Cancer Research Institutes
12.22. North America Basal Cell Carcinoma Treatment Market Attractiveness Analysis
12.22.1. By Surgical Treatment Type
12.22.2. By Drug Type
12.22.3. By Therapy
12.22.4. By End User
12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments
13. Europe Basal Cell Carcinoma Treatment Market Analysis
13.1. Key Findings
13.2. Europe Basal Cell Carcinoma Treatment Market Overview
13.3. Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
13.4. Europe Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.4.1. Surgical Excision
13.4.2. Electrodessication & Cutterage (ED&C)
13.4.3. Moh’s Surgery
13.4.4. Cryosurgery
13.5. Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
13.6. Europe Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.6.1. Topical Treatment
13.6.2. Advanced Medication
13.6.3. Other
13.7. Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
13.8. Europe Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.8.1. Radiation Therapy
13.8.2. Photodynamic Therapy (PDT)
13.8.3. Laser Therapy
13.9. Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
13.10. Europe Basal Cell Carcinoma Treatment Market Forecast, By End User
13.10.1. Hospitals
13.10.2. Specialty Clinics
13.10.3. Cancer Research Institutes
13.11. Europe Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country
13.12. Europe Basal Cell Carcinoma Treatment Market Forecast, by Country
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Europe Basal Cell Carcinoma Treatment Market Analysis, by Country
13.14. Germany Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.14.1. Surgical Excision
13.14.2. Electrodessication & Cutterage (ED&C)
13.14.3. Moh’s Surgery
13.14.4. Cryosurgery
13.15. Germany Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.15.1. Topical Treatment
13.15.2. Advanced Medication
13.15.3. Other
13.16. Germany Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.16.1. Radiation Therapy
13.16.2. Photodynamic Therapy (PDT)
13.16.3. Laser Therapy
13.17. Germany Basal Cell Carcinoma Treatment Market Forecast, By End User
13.17.1. Hospitals
13.17.2. Specialty Clinics
13.17.3. Cancer Research
13.18. U.K. Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.18.1. Surgical Excision
13.18.2. Electrodessication & Cutterage (ED&C)
13.18.3. Moh’s Surgery
13.18.4. Cryosurgery
13.19. U.K. Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.19.1. Topical Treatment
13.19.2. Advanced Medication
13.19.3. Other
13.20. U.K. Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.20.1. Radiation Therapy
13.20.2. Photodynamic Therapy (PDT)
13.20.3. Laser Therapy
13.21. U.K. Basal Cell Carcinoma Treatment Market Forecast, By End User
13.21.1. Hospitals
13.21.2. Specialty Clinics
13.21.3. Cancer Research Institutes
13.22. France Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.22.1. Surgical Excision
13.22.2. Electrodessication & Cutterage (ED&C)
13.22.3. Moh’s Surgery
13.22.4. Cryosurgery
13.23. France Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.23.1. Topical Treatment
13.23.2. Advanced Medication
13.23.3. Other
13.24. France Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.24.1. Radiation Therapy
13.24.2. Photodynamic Therapy (PDT)
13.24.3. Laser Therapy
13.25. France Basal Cell Carcinoma Treatment Market Forecast, By End User
13.25.1. Hospitals
13.25.2. Specialty Clinics
13.25.3. Cancer Research Institutes
13.26. Italy Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.26.1. Surgical Excision
13.26.2. Electrodessication & Cutterage (ED&C)
13.26.3. Moh’s Surgery
13.26.4. Cryosurgery
13.27. Italy Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.27.1. Topical Treatment
13.27.2. Advanced Medication
13.27.3. Other
13.28. Italy Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.28.1. Radiation Therapy
13.28.2. Photodynamic Therapy (PDT)
13.28.3. Laser Therapy
13.29. Italy Basal Cell Carcinoma Treatment Market Forecast, By End User
13.29.1. Hospitals
13.29.2. Specialty Clinics
13.29.3. Cancer Research Institutes
13.30. Spain Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.30.1. Surgical Excision
13.30.2. Electrodessication & Cutterage (ED&C)
13.30.3. Moh’s Surgery
13.30.4. Cryosurgery
13.31. Spain Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.31.1. Topical Treatment
13.31.2. Advanced Medication
13.31.3. Other
13.32. Spain Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.32.1. Radiation Therapy
13.32.2. Photodynamic Therapy (PDT)
13.32.3. Laser Therapy
13.33. Spain Basal Cell Carcinoma Treatment Market Forecast, By End User
13.33.1. Hospitals
13.33.2. Specialty Clinics
13.33.3. Cancer Research Institutes
13.34. Rest of Europe Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
13.34.1. Surgical Excision
13.34.2. Electrodessication & Cutterage (ED&C)
13.34.3. Moh’s Surgery
13.34.4. Cryosurgery
13.35. Rest of Europe Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
13.35.1. Topical Treatment
13.35.2. Advanced Medication
13.35.3. Other
13.36. Rest of Europe Basal Cell Carcinoma Treatment Market Forecast, By Therapy
13.36.1. Radiation Therapy
13.36.2. Photodynamic Therapy (PDT)
13.36.3. Laser Therapy
13.37. Rest of Europe Basal Cell Carcinoma Treatment Market Forecast, By End User
13.37.1. Hospitals
13.37.2. Specialty Clinics
13.37.3. Cancer Research Institutes
13.38. Europe Basal Cell Carcinoma Treatment Market Attractiveness Analysis
13.38.1. By Surgical Treatment Type
13.38.2. By Drug Type
13.38.3. By Therapy
13.38.4. By End User
13.39. PEST Analysis
13.40. Key Trends
13.41. Key Developments
14. Asia Pacific Basal Cell Carcinoma Treatment Market Analysis
14.1. Key Findings
14.2. Asia Pacific Basal Cell Carcinoma Treatment Market Overview
14.3. Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
14.4. Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.4.1. Surgical Excision
14.4.2. Electrodessication & Cutterage (ED&C)
14.4.3. Moh’s Surgery
14.4.4. Cryosurgery
14.5. Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
14.6. Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.6.1. Topical Treatment
14.6.2. Advanced Medication
14.6.3. Other
14.7. Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
14.8. Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Therapy
14.8.1. Radiation Therapy
14.8.2. Photodynamic Therapy (PDT)
14.8.3. Laser Therapy
14.9. Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
14.10. Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By End User
14.10.1. Hospitals
14.10.2. Specialty Clinics
14.10.3. Cancer Research Institutes
14.11. Asia Pacific Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country
14.12. Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, by Country
14.12.1. China
14.12.2. India
14.12.3. Japan
14.12.4. ASEAN
14.12.5. Rest of Asia Pacific
14.13. Asia Pacific Basal Cell Carcinoma Treatment Market Analysis, by Country
14.14. China Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.14.1. Surgical Excision
14.14.2. Electrodessication & Cutterage (ED&C)
14.14.3. Moh’s Surgery
14.14.4. Cryosurgery
14.15. China Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.15.1. Topical Treatment
14.15.2. Advanced Medication
14.15.3. Other
14.16. China Basal Cell Carcinoma Treatment Market Forecast, By Therapy
14.16.1. Radiation Therapy
14.16.2. Photodynamic Therapy (PDT)
14.16.3. Laser Therapy
14.17. China Basal Cell Carcinoma Treatment Market Forecast, By End User
14.17.1. Hospitals
14.17.2. Specialty Clinics
14.17.3. Cancer Research Institutes
14.18. India Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.18.1. Surgical Excision
14.18.2. Electrodessication & Cutterage (ED&C)
14.18.3. Moh’s Surgery
14.18.4. Cryosurgery
14.19. India Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.19.1. Topical Treatment
14.19.2. Advanced Medication
14.19.3. Other
14.20. India Basal Cell Carcinoma Treatment Market Forecast, By Therapy
14.20.1. Radiation Therapy
14.20.2. Photodynamic Therapy (PDT)
14.20.3. Laser Therapy
14.21. India Basal Cell Carcinoma Treatment Market Forecast, By End User
14.21.1. Hospitals
14.21.2. Specialty Clinics
14.21.3. Cancer Research Institutes
14.22. Japan Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.22.1. Surgical Excision
14.22.2. Electrodessication & Cutterage (ED&C)
14.22.3. Moh’s Surgery
14.22.4. Cryosurgery
14.23. Japan Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.23.1. Topical Treatment
14.23.2. Advanced Medication
14.23.3. Other
14.24. Japan Basal Cell Carcinoma Treatment Market Forecast, By Therapy
14.24.1. Radiation Therapy
14.24.2. Photodynamic Therapy (PDT)
14.24.3. Laser Therapy
14.25. Japan Basal Cell Carcinoma Treatment Market Forecast, By End User
14.25.1. Hospitals
14.25.2. Specialty Clinics
14.25.3. Cancer Research Institutes
14.26. ASEAN Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.26.1. Surgical Excision
14.26.2. Electrodessication & Cutterage (ED&C)
14.26.3. Moh’s Surgery
14.26.4. Cryosurgery
14.27. ASEAN Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.27.1. Topical Treatment
14.27.2. Advanced Medication
14.27.3. Other
14.28. Treatment Market Forecast, By Therapy
14.28.1. Radiation Therapy
14.28.2. Photodynamic Therapy (PDT)
14.28.3. Laser Therapy
14.29. ASEAN Basal Cell Carcinoma Treatment Market Forecast, By End User
14.29.1. Hospitals
14.29.2. Specialty Clinics
14.29.3. Cancer Research Institutes
14.30. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
14.30.1. Surgical Excision
14.30.2. Electrodessication & Cutterage (ED&C)
14.30.3. Moh’s Surgery
14.30.4. Cryosurgery
14.31. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
14.31.1. Topical Treatment
14.31.2. Advanced Medication
14.31.3. Other
14.32. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By Therapy
14.32.1. Radiation Therapy
14.32.2. Photodynamic Therapy (PDT)
14.32.3. Laser Therapy
14.33. Rest of Asia Pacific Basal Cell Carcinoma Treatment Market Forecast, By End User
14.33.1. Hospitals
14.33.2. Specialty Clinics
14.33.3. Cancer Research Institutes
14.34. Asia Pacific Basal Cell Carcinoma Treatment Market Attractiveness Analysis
14.34.1. By Surgical Treatment Type
14.34.2. By Drug Type
14.34.3. By Therapy
14.34.4. By End User
14.35. PEST Analysis
14.36. Key Trends
14.37. Key Developments
15. Middle East & Africa Basal Cell Carcinoma Treatment Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Basal Cell Carcinoma Treatment Market Overview
15.3. Middle East & Africa Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
15.4. Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
15.4.1. Surgical Excision
15.4.2. Electrodessication & Cutterage (ED&C)
15.4.3. Moh’s Surgery
15.4.4. Cryosurgery
15.5. Middle East & Africa Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
15.6. Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
15.6.1. Topical Treatment
15.6.2. Advanced Medication
15.6.3. Other
15.7. Middle East & Africa Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
15.8. Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Therapy
15.8.1. Radiation Therapy
15.8.2. Photodynamic Therapy (PDT)
15.8.3. Laser Therapy
15.9. Middle East & Africa Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
15.10. Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By End User
15.10.1. Hospitals
15.10.2. Specialty Clinics
15.10.3. Cancer Research Institutes
15.11. Middle East & Africa Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country
15.12. Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, by Country
15.12.1. GCC
15.12.2. South Africa
15.12.3. Rest of Middle East & Africa
15.13. Middle East & Africa Basal Cell Carcinoma Treatment Market Analysis, by Country
15.14. GCC Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
15.14.1. Surgical Excision
15.14.2. Electrodessication & Cutterage (ED&C)
15.14.3. Moh’s Surgery
15.14.4. Cryosurgery
15.15. GCC Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
15.15.1. Topical Treatment
15.15.2. Advanced Medication
15.15.3. Other
15.16. GCC Basal Cell Carcinoma Treatment Market Forecast, By Therapy
15.16.1. Radiation Therapy
15.16.2. Photodynamic Therapy (PDT)
15.16.3. Laser Therapy
15.17. GCC Basal Cell Carcinoma Treatment Market Forecast, By End User
15.17.1. Hospitals
15.17.2. Specialty Clinics
15.17.3. Cancer Research Institutes
15.18. South Africa Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
15.18.1. Surgical Excision
15.18.2. Electrodessication & Cutterage (ED&C)
15.18.3. Moh’s Surgery
15.18.4. Cryosurgery
15.19. South Africa Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
15.19.1. Topical Treatment
15.19.2. Advanced Medication
15.19.3. Other
15.20. South Africa Basal Cell Carcinoma Treatment Market Forecast, By Therapy
15.20.1. Radiation Therapy
15.20.2. Photodynamic Therapy (PDT)
15.20.3. Laser Therapy
15.21. South Africa Basal Cell Carcinoma Treatment Market Forecast, By End User
15.21.1. Hospitals
15.21.2. Specialty Clinics
15.21.3. Cancer Research Institutes
15.22. Rest of Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
15.22.1. Surgical Excision
15.22.2. Electrodessication & Cutterage (ED&C)
15.22.3. Moh’s Surgery
15.22.4. Cryosurgery
15.23. Rest of Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
15.23.1. Topical Treatment
15.23.2. Advanced Medication
15.23.3. Other
15.24. Rest of Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By Therapy
15.24.1. Radiation Therapy
15.24.2. Photodynamic Therapy (PDT)
15.24.3. Laser Therapy
15.25. Rest of Middle East & Africa Basal Cell Carcinoma Treatment Market Forecast, By End User
15.25.1. Hospitals
15.25.2. Specialty Clinics
15.25.3. Cancer Research Institutes
15.26. Middle East & Africa Basal Cell Carcinoma Treatment Market Attractiveness Analysis
15.26.1. By Surgical Treatment Type
15.26.2. By Drug Type
15.26.3. By Therapy
15.26.4. By End User
15.27. PEST Analysis
15.28. Key Trends
15.29. Key Developments
16. South America Basal Cell Carcinoma Treatment Market Analysis
16.1. Key Findings
16.2. South America Basal Cell Carcinoma Treatment Market Overview
16.3. South America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Surgical Treatment Type
16.4. South America Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
16.4.1. Surgical Excision
16.4.2. Electrodessication & Cutterage (ED&C)
16.4.3. Moh’s Surgery
16.4.4. Cryosurgery
16.5. South America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Drug Type
16.6. South America Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
16.6.1. Topical Treatment
16.6.2. Advanced Medication
16.6.3. Other
16.7. South America Basal Cell Carcinoma Treatment Market Value Share Analysis, By Therapy
16.8. South America Basal Cell Carcinoma Treatment Market Forecast, By Therapy
16.8.1. Radiation Therapy
16.8.2. Photodynamic Therapy (PDT)
16.8.3. Laser Therapy
16.9. South America Basal Cell Carcinoma Treatment Market Value Share Analysis, By End User
16.10. South America Basal Cell Carcinoma Treatment Market Forecast, By End User
16.10.1. Hospitals
16.10.2. Specialty Clinics
16.10.3. Cancer Research Institutes
16.11. South America Basal Cell Carcinoma Treatment Market Value Share Analysis, by Country
16.12. South America Basal Cell Carcinoma Treatment Market Forecast, by Country
16.12.1. Brazil
16.12.2. Mexico
16.12.3. Rest of South America
16.13. South America Basal Cell Carcinoma Treatment Market Analysis, by Country
16.14. Brazil Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
16.14.1. Surgical Excision
16.14.2. Electrodessication & Cutterage (ED&C)
16.14.3. Moh’s Surgery
16.14.4. Cryosurgery
16.15. Brazil Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
16.15.1. Topical Treatment
16.15.2. Advanced Medication
16.15.3. Other
16.16. Brazil Basal Cell Carcinoma Treatment Market Forecast, By Therapy
16.16.1. Radiation Therapy
16.16.2. Photodynamic Therapy (PDT)
16.16.3. Laser Therapy
16.17. Brazil Basal Cell Carcinoma Treatment Market Forecast, By End User
16.17.1. Hospitals
16.17.2. Specialty Clinics
16.17.3. Cancer Research Institutes
16.18. Mexico Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
16.18.1. Surgical Excision
16.18.2. Electrodessication & Cutterage (ED&C)
16.18.3. Moh’s Surgery
16.18.4. Cryosurgery
16.19. Mexico Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
16.19.1. Topical Treatment
16.19.2. Advanced Medication
16.19.3. Other
16.20. Mexico Basal Cell Carcinoma Treatment Market Forecast, By Therapy
16.20.1. Radiation Therapy
16.20.2. Photodynamic Therapy (PDT)
16.20.3. Laser Therapy
16.21. Mexico Basal Cell Carcinoma Treatment Market Forecast, By End User
16.21.1. Hospitals
16.21.2. Specialty Clinics
16.21.3. Cancer Research Institutes
16.22. Rest of South America Basal Cell Carcinoma Treatment Market Forecast, By Surgical Treatment Type
16.22.1. Surgical Excision
16.22.2. Electrodessication & Cutterage (ED&C)
16.22.3. Moh’s Surgery
16.22.4. Cryosurgery
16.23. Rest of South America Basal Cell Carcinoma Treatment Market Forecast, By Drug Type
16.23.1. Topical Treatment
16.23.2. Advanced Medication
16.23.3. Other
16.24. Rest of South America Basal Cell Carcinoma Treatment Market Forecast, By Therapy
16.24.1. Radiation Therapy
16.24.2. Photodynamic Therapy (PDT)
16.24.3. Laser Therapy
16.25. Rest of South America Basal Cell Carcinoma Treatment Market Forecast, By End User
16.25.1. Hospitals
16.25.2. Specialty Clinics
16.25.3. Cancer Research Institutes
16.26. South America Basal Cell Carcinoma Treatment Market Attractiveness Analysis
16.26.1. By Surgical Treatment Type
16.26.2. By Drug Type
16.26.3. By Therapy
16.26.4. By End User
16.27. PEST Analysis
16.28. Key Trends
16.29. Key Developments
17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.2.1. Competitive Benchmarking of key players by price, presence, market share, Drug Types and R&D investment
17.2.2. New Therapy Launches and Therapy Enhancements
17.2.3. Market Consolidation
17.2.3.1. M&A by Regions, Investment and Drug Types
17.2.3.2. M&A Key Players, Forward Integration and Backward Integration
17.3. Company Profiles: Key Players
17.3.1. Valeant Pharmaceuticals International, Inc.
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Therapy Portfolio
17.3.1.4. Business Strategy
17.3.1.5. Recent Developments
17.3.1.6. Company Footprint
17.3.2. Sun Pharmaceuticals Ltd.
17.3.3. F. Hoffmann-La Roche Ltd.
17.3.4. Mylan N.V.
17.3.5. Bausch Health,
17.3.6. Biofrontera,
17.3.7. Merck & Co., Inc.
18. Primary Key Insights